SNPS - Synopsys, Inc. | BullzEye View

SNPS

$438.45 +19.65 (+4.69%)

After Hours: $438.45 +0.00 (+0.00%)

Last updated: Apr 15, 2026 22:49

52-Week Range

$438.45

$376.18 $438.45 $651.73

Fundamentals Overview

Synopsys, Inc. is near the low of its 52-week range with premium valuation, trending upward today.

Valuation premium

P/E 64.4 P/B 2.3 P/S 10.49

Intrinsic value (DCF)

-31.3% downside vs price

Profitability

Net margin 13.8%

Risk (Beta)

1.15 — in line vol

Earnings & growth

EPS $6.81 Rev +6.8% Profit -85.6% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 65% confidence Risk: Moderate Volatility — Beta 1.15. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B-

Pressures (Sell):

DCF 31.3% downside vs price · Sentiment weakening (5 downgrades) · 3M vs S&P 500: -18.5% · 3M vs Technology sector: -20.2%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$83.99B

P/E (TTM)

64.37

EPS (TTM)

$6.81

Dividend Yield

N/A

52-Week Range

$376.18 - $651.73

Volume vs Avg

N/A

Beta

1.15

About

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also prov...

Sector: Technology

Headquarters: US

Employees: 28,000

IPO Date: Feb 1992

Website: www.synopsys.com

Beta: 1.15 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 9, Equal Weight: 5, Neutral: 5, Outperform: 1, Overweight: 9, Underperform: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $301.30; current price is $438.45. That’s a -31.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	64.37
DCF value (model)	$301.30 (-31.3% vs price)
PEG (TTM)	N/A
P/B (TTM)	2.3
P/S (TTM)	10.49
P/FCF (TTM)	36.86
Liquidity & enterprise
Current Ratio (TTM)	0.86
Quick Ratio (TTM)	0.8
Cash Ratio (TTM)	0.34
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	13.75%
Gross margin (TTM)	75.14%
Operating margin (TTM)	10.82%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for SNPS.

Analyst Sentiment at a Glance

B- Sentiment Weakening

Buy 9Equal Weight 5Neutral 5Outperform 1Overweight 9Underperform 1

3 upgrades, 5 downgrades

Price Target Consensus

Current $438.45

Median $550.00

Consensus $543.57

Low consensus $455.00

High consensus $600.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Morgan Stanley	downgrade	Overweight	Equal Weight	2026-02-27
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-02-26
Piper Sandler	maintain	Neutral	Neutral	2026-02-26
Rosenblatt	maintain	Buy	Buy	2026-02-26
Rosenblatt	maintain	Buy	Buy	2026-02-20
Piper Sandler	downgrade	Overweight	Neutral	2026-01-13
Morgan Stanley	maintain	Overweight	Overweight	2025-12-12
Piper Sandler	maintain	Overweight	Overweight	2025-12-11
JP Morgan	maintain	Overweight	Overweight	2025-12-11
Keybanc	maintain	Overweight	Overweight	2025-12-11
Needham	maintain	Buy	Buy	2025-12-11
B of A Securities	upgrade	Neutral	Buy	2025-12-11
Rosenblatt	maintain	Buy	Buy	2025-12-11
Wells Fargo	maintain	Equal Weight	Equal Weight	2025-12-11
Rosenblatt	upgrade	Neutral	Buy	2025-12-09
B of A Securities	upgrade	Underperform	Neutral	2025-12-08
Keybanc	maintain	Overweight	Overweight	2025-12-03
Wells Fargo	maintain	Equal Weight	Equal Weight	2025-11-25
Mizuho	maintain	Outperform	Outperform	2025-09-11
Morgan Stanley	maintain	Overweight	Overweight	2025-09-11
Needham	maintain	Buy	Buy	2025-09-10
Baird	downgrade	Outperform	Neutral	2025-09-10
Piper Sandler	maintain	Overweight	Overweight	2025-09-10
Stifel	maintain	Buy	Buy	2025-09-10
JP Morgan	maintain	Overweight	Overweight	2025-09-10
B of A Securities	downgrade	Buy	Underperform	2025-09-10
Wells Fargo	maintain	Equal Weight	Equal Weight	2025-09-10
Rosenblatt	downgrade	Buy	Neutral	2025-09-10
Keybanc	maintain	Overweight	Overweight	2025-09-10
Goldman Sachs	maintain	Buy	Buy	2025-09-10